Company news

Share this article:

Pharmaceutical promotion measurement firm ImpactRx has acquired Paragon Research & Consulting, Inc. of West Chester, PA. Paragon is expected to apply its analytical and custom research capabilities to ImpactRx's proprietary data to evaluate of the pharmaceutical market and of individual company and brand performance.

Teva Pharmaceutical Industries announced it has entered into a definitive agreement to acquire CoGenesys, a privately held biopharmaceutical company with a broad based biotechnology platform and focused on the development of peptide- and protein-based medicines across broad therapeutic categories. CoGenesys was established in 2005 as a division within Human Genome Sciences Inc. to focus on early drug development and was spun off as an independent company in June 2006.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.